TB-Related Articles
Aboukheir MK, Alvarado-Ramy F, Fernandez Vazquez M, Joglar O. Notes from the Field: Tuberculosis Control in the Aftermath of Hurricane Maria – Puerto Rico, 2017. MMWR Morb Mortal Wkly Rep.external icon 2019 Jan 18;68(2):46-47. doi: 10.15585/mmwr.mm6802a6. PMID: 30653488.
Agizew T, Boyd R, Auld AF, Payton L, Pals SL, Lekone P, Chihota V, Finlay A. Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.external icon Int J Tuberc Lung Dis. 2019 Jan 1;23(1):82-92. doi: 10.5588/ijtld.18.0203. PMID:30674379.
Agizew T, Chihota V, Nyirenda S, Tedla Z, Auld AF, Mathebula U, Mathoma A, Boyd R, Date A, Pals SL, Lekone P, Finlay A. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial. BMC Infect Dis.external icon 2019 Dec 16;19(1):1058. doi: 10.1186/s12879-019-4697-5. PMID: 31842773.
Armstrong GL, MacCannell DR, Taylor J, Carleton HA, Neuhaus EB, Bradbury RS, Posey JE, Gwinn M. Pathogen Genomics in Public Health. external iconN Engl J Med. 2019 Dec 26;381(26):2569-2580. doi: 10.1056/NEJMsr1813907. PMID: 31881145.
Armstrong LR, Winston CA, Stewart B, Tsang CA, Langer AJ, Navin TR. Changes in tuberculosis epidemiology, United States, 1993-2017. Int J Tuberc Lung Dis.external icon 2019 Jul 1;23(7):797-804. doi: 10.5588/ijtld.18.0757. PMID: 31439110.
Bardenheier BH, Pavkov ME, Winston CA, Klosovsky A, Yen C, Benoit S, Gravenstein S, Posey DL, Phares CR. Prevalence of Tuberculosis Disease Among Adult US-Bound Refugees with Chronic Kidney Disease.external icon J Immigr Minor Health. 2019 Jan 5. doi: 10.1007/s10903-018-00852-8. [Epub ahead of print]. PMID: 30612283.
Belanger A, Morris SB, Brostrom R, Yost D, Goswami N, Oxtoby M, Moore M, Westenhouse J, Barry PM, Shah NS. Introduction and evaluation of multidrug-resistant tuberculosis supplemental surveillance in the United States.external icon J Clin Tuberc Other Mycobact Dis. 2019;15:100090.
Bonney W, Price SF, Miramontes R. Design and Implementation of Data Exchange Formats for Molecular Detection of Drug-Resistant Tuberculosis.external icon AMIA Jt Summits Transl Sci Proc. 2019 May 6;2019:686-695. eCollection 2019. PMID: 31259025.
Centers for Disease Control and Prevention. Nationwide Shortage of Tuberculin Skin Test Antigens: CDC Recommendations for Patient Care and Public Health Practice. MMWR Morb Mortal Wkly Rep.external icon 2019 Jun 21;68(24):552-553. doi: 10.15585/mmwr.mm6824a4. PMID: 31220054.
Cowger TL, Wortham JM, Burton DC. Epidemiology of tuberculosis among children and adolescents in the USA, 2007-17: An analysis of national surveillance data. Lancet Public Health.external icon 2019 Oct;4(10):e506-e516. doi: 10.1016/S2468-2667(19)30134-3. Epub 2019 Aug 21. PMID: 31446052.
de Vos M, Ley SD, Wiggins KB, Derendinger B, Dippenaar A, Grobbelaar M, Reuter A, Dolby T, Burns S, Schito M, Engelthaler DM, Metcalfe J, Theron G, van Rie A, Posey J, Warren R, Cox H. Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.external icon N Engl J Med. 2019 May 30;380(22):2178-2180. doi: 10.1056/NEJMc1815121. No abstract available. PMID: 31141643.
Dirlikov E, Thomas D, Yost D, Tejada-Vera B, Bermudez M, Joglar O, Chorba T. Tuberculosis Surveillance and Control, Puerto Rico, 1898–2015. Emerg Infect Dis. 2019;25(3):538-546. doi:10.3201/eid2503.181157.
Goodell AJ, Shete PB, Vreman R, McCabe D, Porco TC, Barry PM, Flood J, Marks SM, Hill A, Cattamanchi A, Kahn JG. Outlook for tuberculosis elimination in California: An individual-based stochastic model.external icon PLoS One. 2019 Apr 9;14(4):e0214532. doi: 10.1371/journal.pone.0214532. eCollection 2019. PMID: 30964878.
Goswami ND, Mase S, Griffith D, Bhavaraju R, Lardizabal A, Lauzardo M, Chen L, Wilson J, Chappelle C, Haley CA. Tuberculosis in the United States: Medical Consultation Services Provided by 5 Tuberculosis Regional Training and Medical Consultation Centers, 2013-2017.external icon Open Forum Infect Dis. 2019 Apr 4;6(6):ofz167. doi: 10.1093/ofid/ofz167. eCollection 2019 Jun. PMID: 31205971.
Haddad MB, Lash TL, Hill AN, Navin TR, Castro KG, Gandhi NR, Winston CA. Robustness of NHANES Estimates of the U.S. Prevalence of a Positive Tuberculin Skin Test.external icon Epidemiology. 2019 Nov 14. doi: 10.1097/EDE.0000000000001141. [Epub ahead of print]. PMID: 31764278.
Haddad MB, Raz KM, Hill AN, Navin TR, Castro KG, Winston CA, Gandhi NR, Lash TL. Influence of County Sampling on Past Estimates of Latent Tuberculosis Infection Prevalence.external icon Ann Am Thorac Soc. 2019 Mar 19. doi: 10.1513/AnnalsATS.201901-062RL. PMID: 30888833.
Hedges KNC, Borisov AS, Saukkonen JJ, Scott NA, Hecker EJ, Bozeman L, Dukes Hamilton C, Kerrigan A, Bessler P, Moreno-Martinez A, Arevalo B, Goldberg SV. Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen.external icon Clin Trials. 2019 Nov 6:1740774519885380. doi: 10.1177/1740774519885380. [Epub ahead of print]. PMID: 31690107.
Holland DP, Alexander S, Onwubiko U, Goswami ND, Yamin A, Mohamed O, Sales RM, Grant G, Talboy P, Ray S, Toomey KE. Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015-2017.external icon Emerg Infect Dis. 2019 Mar;25(3):593-595. doi: 10.3201/eid2503.181678. PMID: 30789335.
Imada EK, Roberson EK, Goswami ND, Brostrom RJ, Moser K, Tardivel K. Notes from the Field: Meningeal and Pulmonary Tuberculosis on a Commercial Fishing Vessel – Hawaii, 2017. MMWR Morb Mortal Wkly Rep.external icon 2019 Jun 21;68(24):554-555. doi: 10.15585/mmwr.mm6824a5. PMID: 31220056.
Iqbal SA, Armstrong LR, Kammerer JS, Truman BI. Risk Factors for and Trends in Isoniazid Monoresistance at Diagnosis of Tuberculosis-United States, 1993-2016.external icon J Public Health Manag Pract. 2019 Oct 31. doi: 10.1097/PHH.0000000000001060. [Epub ahead of print]. PMID: 31688735.
Iqbal SA, Isenhour CJ, Mazurek G, Langer AJ, Chang MH, Truman BI. Factors Associated With Latent Tuberculosis Infection Treatment Failure Among Patients With Commercial Health Insurance-United States, 2005-2016.external icon J Public Health Manag Pract. 2019 Oct 31. doi: 10.1097/PHH.0000000000001077. [Epub ahead of print]. PMID: 31688742.
Lam CK, Fluegge K, Macaraig M, Burzynski J. Cost savings associated with video directly observed therapy for treatment of tuberculosis. Int J Tuberc Lung Dis.external icon 2019 Nov 1;23(11):1149-1154. doi: 10.5588/ijtld.18.0625. PMID: 31718750.
Langer AJ, Navin TR, Winston CA, LoBue P. Epidemiology of Tuberculosis in the United States.external icon Clin Chest Med. 2019 Dec;40(4):693-702. doi: 10.1016/j.ccm.2019.07.001. Review. PMID: 31731978.
Lienhardt C, Vernon AA, Cavaleri M, Nambiar S, Nahid P. Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance. PLoS Med.external icon 2019 Sep 6;16(9):e1002915. doi: 10.1371/journal.pmed.1002915. eCollection 2019 Sep. PMID: 31490921.
Lo TQ, Matlhare L, Mugisha K, Lere TD, Ho-Foster A, Boyd R, Cavanaugh J, Ncube R, Steenhoff AP, Arscott-Mills T. Initiation of anti-tuberculosis treatment in children following gastric aspirate testing, Botswana, 2008-2012.external icon Int J Tuberc Lung Dis. 2019 Mar 1;23(3):315-321. doi: 10.5588/ijtld.18.0404. PMID: 30871662.
Mahoney D, Chorba T. Romanticism, Mycobacterium, and the Myth of the Muse. Emerg Infect Dis. 2019;25(3):617-618. doi:10.3201/eid2503.ac2503.
Marks SM, Katz DJ, Davidow AL, Pagaoa MA, Teeter LD, Graviss EA. The Impact of HIV Infection on TB Disparities Among US-Born Black and White Tuberculosis Patients in the United States.external icon J Public Health Manag Pract. 2019 Feb 14. doi: 10.1097/PHH.0000000000000949. [Epub ahead of print]. PMID:30789591.
Marks SM, Woodruff RY, Owusu-Edusei K, Asay GRB, Hill AN. Estimates of Testing for Latent Tuberculosis Infection and Cost, United States, 2013. Public Health Rep.external icon 2019 Sep/Oct;134(5):522-527. doi: 10.1177/0033354919862688. Epub 2019 Jul 24. PMID: 31339816.
Mase S, Chorba T, Parks S, Belanger A, Dworkin F, Seaworth B, Warkentin J, Barry P, Shah N. Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis in the United States.external icon Clin Infect Dis. 2019 Sep 26. pii: ciz914. doi: 10.1093/cid/ciz914. [Epub ahead of print]. PMID: 31556947.
Mase SR, Chorba T. Treatment of Drug-Resistant Tuberculosis.external icon Clin Chest Med. 2019 Dec;40(4):775-795. doi: 10.1016/j.ccm.2019.08.002. Review. PMID: 31731984.
Mase SR, Samron R, Ashkin D, Castro KG, Ryan S, Seaworth B, Chen L, Lardizabal A, Tuckey D, Khan A, Posey DL, Chappelle C, Temesgen Z. Tuberculosis Regional Training and Medical Consultation Centers in the United States: Characteristics, outcomes, and quality of medical consultations, June 1, 2010 – May 31, 2014. J Clin Tuberc Other Mycobact Dis.external icon 2019 Jul 2;17:100114. doi: 10.1016/j.jctube.2019.100114. eCollection 2019 Dec. PMID: 31788557.
Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay G, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California.external icon Am J Respir Crit Care Med. 2019 Oct 18. doi: 10.1164/rccm.201907-1289OC. [Epub ahead of print]. PMID: 31626560.
Miller AP, Malekinejad M, Horváth H, Blodgett JC, Kahn JG, Marks SM. Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review.external icon PLoS One. 2019 Sep 30;14(9):e0223077. doi: 10.1371/journal.pone.0223077. eCollection 2019. PMID: 31568507.
Mongkolrattanothai T, Lambert LA, Winston CA. Tuberculosis among healthcare personnel, United States, 2010-2016. Infect Control Hosp Epidemiol.external icon 2019 Jun;40(6):701-704. doi: 10.1017/ice.2019.76. Epub 2019 Apr 23. PMID: 31012401.
Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, Cattamanchi A, Cegielski JP, Chen L, Daley CL, Dalton TL, Duarte R, Fregonese F, Horsburgh CR Jr, Ahmad Khan F, Kheir F, Lan Z, Lardizabal A, Lauzardo M, Mangan JM, Marks SM, McKenna L, Menzies D, Mitnick CD, Nilsen DM, Parvez F, Peloquin CA, Raftery A, Schaaf HS, Shah NS, Starke JR, Wilson JW, Wortham JM, Chorba T, Seaworth B. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med.external icon 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST. PMID: 31729908.
Nwana N, Marks SM, Lan E, Chang AH, Holcombe M, Morris SB. Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness.external icon PLoS One. 2019 Mar 13;14(3):e0213524. doi: 10.1371/journal.pone.0213524. eCollection 2019. PMID: 30865724.
Pratt RH, Manangan LP, Cummings CN, Langer AJ. Noncountable Tuberculosis Case Reporting, National Tuberculosis Surveillance System, United States, 2010-2014. Public Health Rep.external icon 2020 Jan;135(1):18-24. doi: 10.1177/0033354919884302. Epub 2019 Nov 13. PMID: 31722186.
Reichler MR, Khan A, Sterling TR, Zhao H, Chen B, Yuan Y, Moran J, McAuley J, Mangura B; Tuberculosis Epidemiologic Studies Consortium Task Order 2 Team. Risk Factors for Tuberculosis and Effect of Preventive Therapy Among Close Contacts of Persons with Infectious Tuberculosis.external icon Clin Infect Dis. 2019 May 24. pii: ciz438. doi: 10.1093/cid/ciz438. [Epub ahead of print]. PMID: 31127813.
Sable SB, Posey JE, Scriba TJ. Tuberculosis Vaccine Development: Progress in Clinical Evaluation.external icon. Clin Microbiol Rev. 2019 Oct 30;33(1). pii: e00100-19. doi: 10.1128/CMR.00100-19. Print 2019 Dec 18. Review. PMID: 31666281.
Schmit KM, Brostrom R, Largen A, Pyan A, Wang Z, Mase S, Morris S. Higher Rates of Tuberculosis Among Class B1 Filipino Immigrants to Hawaii Compared to Nationwide, 2010-2014.external icon J Immigr Minor Health. 2019. Feb 26. doi: 10.1007/s10903-019-00855-z. [Epub ahead of print]. PMID: 30806953.
Sharling L, Marks SM, Goodman M, Chorba T, Mase S. Rifampin-Resistant Tuberculosis In The United States, 1998-2014.external icon Clin Infect Dis. 2019 Jun 22. pii: ciz491. doi: 10.1093/cid/ciz491. [Epub ahead of print]. PMID: 31233131.
Shrestha S, Cherng S, Hill AN, Reynolds S, Flood J, Barry PM, Readhead A, Oxtoby M, Lauzardo M, Privett T, Marks SM, Dowdy DW. Impact and Effectiveness of State-level Tuberculosis interventions in California, Florida, New York and Texas: A model-based analysis.external icon Am J Epidemiol. 2019 Jun 28. pii: kwz147. doi: 10.1093/aje/kwz147. [Epub ahead of print]. PMID: 31251797.
Sosa LE, Njie GJ, Lobato MN, Bamrah Morris S, Buchta W, Casey ML, Goswami ND, Gruden M, Hurst BJ, Khan AR, Kuhar DT, Lewinsohn DM, Mathew TA, Mazurek GH, Reves R, Paulos L, Thanassi W, Will L, Belknap R. Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019. MMWR Morb Mortal Wkly Rep. 2019 May 17;68(19):439-443. doi: 10.15585/mmwr.mm6819a3. PMID:
31099768.
Talwar A, Tsang, CA, Price SF, Pratt RH, Walker WL, Schmit KM, Langer AJ. Tuberculosis — United States, 2018. MMWR Morb Mortal Wkly Rep. 2019 March 22; 68(11);257–262.
Tornheim JA, Starks AM, Rodwell TC, Gardy JL, Walker TM, Cirillo DM, Jayashankar L, Miotto P, Zignol M, Schito M. Building the framework for standardized clinical laboratory reporting of next generation sequencing data for resistance-associated mutations in Mycobacterium tuberculosis complex.external icon Clin Infect Dis. 2019 Mar 18. pii: ciz219. doi: 10.1093/cid/ciz219. [Epub ahead of print]. PMID: 30883637.
Tsang CA, Shah N, Armstrong LR, Marks SM. Eligibility for a Shorter Treatment Regimen for Multidrug-resistant Tuberculosis in the United States, 2011-2016.external icon Clin Infect Dis. 2019 Apr 4. pii: ciz263. doi: 10.1093/cid/ciz263. [Epub ahead of print]. PMID: 30944927.
Venkatappa TK, Punnoose R, Katz DJ, Higgins MP, Banaei N, Graviss EA, Belknap RW, Ho CS. Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection. J Clin Microbiol.external icon 2019 Oct 23;57(11). pii: e00985-19. doi: 10.1128/JCM.00985-19. Print 2019 Nov. PMID: 31462550.
Vernon A, Bishai W. Modelling Treatment of Latent TB: Shortening the Leap of Faith?external icon Am J Respir Crit Care Med. 2019 Nov 25. doi: 10.1164/rccm.201911-2160ED. [Epub ahead of print]. PMID: 31765598.
Vonnahme L, Haddad MB, Navin TR. Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011-2012 external icon. Emerg Infect Dis 2019; 25(10): 1949–1951. doi: 10.3201/eid2510.190439. PMID: 31538921.
Wansaula Z, Wortham JM, Mindra G, Haddad MB, Salinas JL, Ashkin D, Morris SB, Grant GB, Ghosh S, Langer AJ. Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004-2015. Emerg Infect Dis.external icon 2019 Mar;25(3):451-456. doi: 10.3201/eid2503.180686. PMID: 30789145.
Wilson JW, Nilsen DM, Marks SM. Multidrug Resistant Tuberculosis in Patients with HIV: Management Considerations within High-Resourced Settings. Ann Am Thorac Soc.external icon 2019 Jul 31. doi: 10.1513/AnnalsATS.201902-185CME. [Epub ahead of print]. PMID: 31365831.
Zimba O, Tamuhla T, Basotli J, Letsibogo G, Pals S, Mathebula U, Mathoma A, Serumola C, Ramogale K, Boyd R, Tran T, Finlay A, Auld A, Date A, Alexander H, Chihota V, Agizew T. The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear.external icon Pan Afr Med J. 2019 Jun 13;33:110. doi: 10.11604/pamj.2019.33.110.15319. eCollection 2019. PMID: 31489088.